CD4+CD25HIGHFOXP3+T-REGULATORY CELLS IN CROHN'S DISEASE PATIENTS TREATED WITH INFLIXIMAB

被引：0
|
作者：
Di Sabatino, A. [1 ]
Rosado, M. [2 ]
Biancheri, P. [1 ]
Cazzola, P. [1 ]
Rovedatti, L. [1 ]
Vanoli, A. [1 ]
Cantoro, L. [1 ]
Carsetti, R. [2 ]
Corazza, G. R. [1 ]
机构：
[1] Univ Pavia, Fdn IRCCS Policlin S Matteo, Ctr Studio & Cura Malattie Infiammatorie Cron Int, Dept Med 1, Pavia, Italy
[2] IRCCS Osped Pediat Bambino Gesu, Res Ctr, Rome, Italy
来源：
DIGESTIVE AND LIVER DISEASE | 2008年 / 40卷
关键词：
D O I：
10.1016/S1590-8658(08)60111-5
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
OC3.03.6
引用
收藏
页码：S43 / S44
页数：2
相关论文
共 50 条
  • [1] CD4+Cd25highfoxp3+T-regulatory cells in Crohn's disease patients treated with infliximab
    Di Sabatino, Antonio
    Rosado, Manuela
    Biancheri, Paolo
    Cazzola, Paolo
    Rovedatti, Laura
    Carsetti, Rita
    MacDonald, Thomas T.
    Corazza, Gino R.
    GASTROENTEROLOGY, 2008, 134 (04) : A660 - A660
  • [2] CD4+CD25highFoxP3+ Regulatory T-cells in Hematologic Diseases
    Moon, Hee-Won
    Kim, Bo Hyun
    Park, Chul Min
    Hur, Mina
    Yun, Yeo-Min
    Kim, Sung-Yong
    Lee, Mark Hong
    KOREAN JOURNAL OF LABORATORY MEDICINE, 2011, 31 (04): : 231 - 237
  • [3] Characterization of Foxp3+Cd4+Cd25+ regulatory T cells in human Crohn's disease (CD)
    Saruta, Masayuki
    Yu, Qi
    Kwan, Lola Y.
    Banham, Alison H.
    Papadakis, Konstantinos A.
    GASTROENTEROLOGY, 2007, 132 (04) : A557 - A557
  • [4] Increased Frequency of CD4+CD25highFoxP3+ Regulatory T Cells in Patients with Hepatocellular Carcinoma
    Feng, Xi
    Li, Bo
    Ye, Hui
    Long, Dan
    ARCHIVUM IMMUNOLOGIAE ET THERAPIAE EXPERIMENTALIS, 2011, 59 (04) : 309 - 314
  • [5] Increased Frequency of CD4+CD25highFoxP3+ Regulatory T Cells in Patients with Hepatocellular Carcinoma
    Xi Feng
    Bo Li
    Hui Ye
    Dan Long
    Archivum Immunologiae et Therapiae Experimentalis, 2011, 59 : 309 - 314
  • [6] Size and diversity of human CD4+CD25HIGHFoxp3+ regulatory T cells repertoire
    Fazilleau, N.
    Bachelez, H.
    Gougeon, M. L.
    Viguier, M.
    JOURNAL OF INVESTIGATIVE DERMATOLOGY, 2007, 127 (10) : 2481 - 2481
  • [7] Influence of pharmacological immunomodulatory agents on CD4+CD25highFoxP3+ T regulatory cells in humans
    Wang, Xiao-Jun
    Leveson-Gower, Dennis
    Golab, Karolina
    Wang, Ling-Jia
    Marek-Trzonkowska, Natalia
    Krzystyniak, Adam
    Wardowska, Anna
    Millis, J. Michael
    Trzonkowski, Piotr
    Witkowski, Piotr
    INTERNATIONAL IMMUNOPHARMACOLOGY, 2013, 16 (03) : 364 - 370
  • [8] CD4+CD25+ regulatory T cells in patients with Behcet's disease
    Hamzaoui, K.
    Hamzaoui, A.
    Houman, H.
    CLINICAL AND EXPERIMENTAL RHEUMATOLOGY, 2006, 24 (05) : S71 - S78
  • [9] Enhanced functionality of CD4+CD25highFoxP3+ regulatory T cells in the peripheral blood of patients with prostate cancer
    Yokokawa, Junko
    Remondo, Cinzia
    Gulley, James L.
    Arlen, Philip M.
    Schlom, Jeffrey
    Tsang, Kwong Y.
    CLINICAL CANCER RESEARCH, 2008, 14 (04) : 1032 - 1040
  • [10] Epigenetic enzymes are the therapeutic targets for CD4+CD25+/highFoxp3+ regulatory T cells
    Lopez-Pastrana, Jahaira
    Shao, Ying
    Chernaya, Valeria
    Wang, Hong
    Yang, Xiao-Feng
    TRANSLATIONAL RESEARCH, 2015, 165 (01) : 221 - 240
12345